Jeffrey Ubben
ValueAct Holdings
Jeffrey Ubben Morgan Stanley stake
total: 107
ValueAct Holdings MS trades
- Total transactions:
- 14
- New positions:
- 1
- Sold out:
- 1
- Added:
- 5
- Reduced:
- 7
- Held since:
- 2016 Q2
- Held for:
- 19 quarters
- Latest activity:
- 2021 Q1
According to 2026 Q2 report, Jeffrey Ubben doesn't hold any Morgan Stanley (MS) shares. To date, the estimated cost basis is nearly $29.15 for "buy" trades and estimated average "sell" price is $49.9. ValueAct Holdings first purchased MS in 2016 Q2, initially acquiring about 38.00M shares. Since the initial investment in Morgan Stanley (MS), ValueAct Holdings has made 13 more transactions.
When did Jeffrey Ubben sell Morgan Stanley (MS)?
Jeffrey Ubben sold off the entire Morgan Stanley (MS) position in 2021 Q1.
When did Jeffrey Ubben buy Morgan Stanley (MS)?
Jeffrey Ubben first invested in Morgan Stanley (MS) in 2016 Q2 at the reported quarter-end price of $25.98 per share.
What's the cost basis of ValueAct Holdings's MS stake?
The estimated cost basis for Morgan Stanley (MS) stake is around $29.15 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $29.15
- Weighted AVG sell price:
- $49.90
Jeffrey Ubben's historical trades in Morgan Stanley
14 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q1
|
0.00%
|
0
|
$68.53
|
|
-100% (-8,283,722)
|
-6.58%
|
|
2020 Q4
|
6.58%
|
$68.53
|
-27.97% (-3,216,278)
|
|||
|
2020 Q3
|
7.82%
|
$48.35
|
-19.30% (-2,750,000)
|
|||
|
2020 Q1
|
6.96%
|
$34.00
|
-5.00% (-750,000)
|
|||
|
2019 Q4
|
7.76%
|
$51.12
|
-32.58% (-7,250,000)
|
|||
|
2019 Q3
|
10.24%
|
$42.67
|
-15.17% (-3,978,561)
|
|||
|
2018 Q4
|
12.95%
|
$39.65
|
+26.04% (+5,418,091)
|
|||
|
2018 Q3
|
9.53%
|
$46.57
|
+11.23% (+2,100,850)
|
|||
|
2018 Q2
|
8.03%
|
$47.40
|
+4.18% (+750,000)
|
|||
|
2017 Q4
|
9.53%
|
$52.47
|
+0.42% (+75,000)
|
|||
|
2017 Q1
|
6.41%
|
$42.84
|
-33.52% (-9,016,380)
|
|||
|
2016 Q4
|
9.33%
|
$42.25
|
-35.80% (-14,999,000)
|
|||
|
2016 Q3
|
11.69%
|
$32.06
|
+10.26% (+3,900,000)
|
|||
|
2016 Q2
|
8.96%
|
$25.98
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.